2nd Quarter - Report — HEALTHFUTURES, LLC for LIFE TECHNOLOGIES (2010)

Firm

HEALTHFUTURES, LLC

Client

LIFE TECHNOLOGIES

Income

$50,000

Expenses

—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

HR 5440, Genomics and Personalized Medicine Act, Personalized medicine HR 805, Strengthening America's Public Health System Act, Pandemic influenza Regulation and reimbursement of laboratory developed tests Regulatory science

Lobbyist	Covered position, as disclosed
JENNIFER RACHEL LEIB	—
KATHRYN SCHUBERT	—

Contacted: Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); HOUSE OF REPRESENTATIVES; Natl Science Foundation (NSF); SENATE; Natl Institutes of Health (NIH)

Bills named: H.R. 5440 (111th), H.R. 805 (111th)

Medical/Disease Research/Clinical Labs MED

HR 5440, Genomics and Personalized Medicine Act, Personalized medicine No Bill#, Genomic Research and Accessibility Act, DNA patents HR 805, Strengthening America's Public Health System Act, Pandemic influenza HR 5116, America Competes Reauthorization Act, bioscience research program at NIST S. 1649, Weapons of Mass Destruction Prevention and Preparedness Act, pandemic influenza

Lobbyist	Covered position, as disclosed
JENNIFER RACHEL LEIB	—
KATHRYN SCHUBERT	—

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Natl Science Foundation (NSF); Natl Institutes of Health (NIH)

Bills named: H.R. 805 (111th), H.R. 5440 (111th), H.R. 5116 (111th), S. 1649 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.